Serono News
Most Popular Serono Story
Merck KGaA buying control of Serono
Germany's Merck KGaA is buying the Bertarelli family's 64.5 percent interest in Switzerland's Serono. The $13.3 billion deal gives the family a 20 percent premium over yesterday's stock price. Serono also announced that its oral cladribine for multiple sclerosis had been fast tracked by the FDA. The family had long signaled its interest in finding a buyer for its stake in the biotech company, but recently had appeared to back off that strategy after failing to put a deal together. Goldman …
... Read more...Latest Headlines
- January 4, 2007
- January 3, 2007
- December 7, 2006
- November 26, 2006
- November 20, 2006
- November 19, 2006
- October 25, 2006
- October 15, 2006
- October 1, 2006
- September 27, 2006
- September 24, 2006
- September 20, 2006
- September 13, 2006
- August 17, 2006
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
